Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver disorders

Seminars in Liver Disease

Volumn 20, Issue 3, 2000, Pages 373-384

  Lee, J ^a   Boyer, J L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cholangiocyte; Cholestasis; Export pumps; Hepatocyte; Membrane transporters

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ESTROGEN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

BASOLATERAL MEMBRANE; BILE SECRETION; CHOLESTASIS; DRUG INDUCED DISEASE; GENE MUTATION; HUMAN; INTRAHEPATIC BILE DUCT; LIVER REGENERATION; MEMBRANE TRANSPORT; MOLECULAR CLONING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; TRANSPORT KINETICS;

EID: 0033744558     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-9390     Document Type: Review

References (124)

1. Molecular pathogenesis of cholestasis
2. Intrahepatic cholestasis: Order out of chaos
3. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome
4. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome
5. Mutations in the canalicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome
6. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis
7. Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24
8. Defect on multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis
9. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis
10. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis
11. Liver diseases in infancy and childhood
12. Molecular regulation of hepatocellular transport systems in cholestasis
13. Molecular aspects of hepatobiliary transport
14. Bile formation
15. Regulation of transmembrane electrical potential gradient in rat hepatocytes in situ
16. Cell membrane and transepithelial voltages and resistances in isolated rat hepatocyte couplets
17. Sinusoidal (basolateral) bile salt uptake systems of hepatocytes
18. +/bile acid cotransport system
19. Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter
20. Expression cloning of a rat liver Na+-independent organic anion transporter
21. Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver
22. Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2
23. Localization and function of the organic anion-transporting polypeptide oatp2 in rat liver
24. Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain
25. Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1
26. Molecular characterization and functional regulation of a novel rat liver-specific organic anion transporter rlst-1
27. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane
28. A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl- CoA reductase inhibitor transporters
29. Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity, and MRP2-mediated drug resistance
30. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in Eisai hyperbilirubinemic rats
31. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3)
32. Characterization of inducible nature of MRP3 in rat liver
33. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
34. Phosphatidylcholine translocase: A physiological role for the mdr2 gene
35. The role of mdr2 P-glycoprotein in hepatobiliary lipid transport
36. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene
37. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats
38. Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver
39. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione
40. Relation between biliary glutathione excretion and bile acid-independent bile flow
41. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver
42. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis
43. Bile acid transport by the rat liver canalicular bile acid transport/ecto-ATPase protein is dependent on ATP but not on its own ecto-ATPase activity
44. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues
45. The function of Gp170, the multidrug resistance gene product, in rat liver canalicular membrane vesicles
46. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologs of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines
47. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells
48. The multidrug resistance protein family
49. ATP-dependent aminophospholipid translocase activity in rat canalicular membrane vesicles and its relationship to FICl [Abstract]
50. Vesicle targeting to the apical domain regulates bile excretory function in isolated rat hepatocyte couplets
51. Cyclic AMP stimulates sorting of the canalicular organic anion transporter (Mrp2/cMoat) to the apical domain in hepatocyte couplets
52. Ectonucleotidases, purine nucleoside transporter, and function of the bile canalicular plasma membrane of the hepatocyte
53. Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver
54. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells
55. 3 transport in cultured human intrahepatic bile duct cells
56. Ion transporters that regulate intracellular pH and secretion in bile duct epthelial cells
57. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis
58. Hepatobiliary disease in cystic fibrosis
59. Liver involvement in cystic fibrosis
60. Effect of endotoxin on bile acid transport in rat liver: A potential model for sepsis-associated cholestasis
61. Sepsis-associated cholestasis
62. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents
63. Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis
64. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: Impaired uptake and secretion
65. The rat canalicular conjugate export pump (mrp 2) is down-regulated in intrahepatic and obstructive cholestasis
66. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors
67. Up-regulation of the multidrug resistance genes, Mrp1 and Mdrlb, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver
68. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat
69. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters
70. Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis
71. Hyperalimentation-associated jaundice: An example of a serum factor inducing cholestasis in rats
72. Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver
73. Decreased bilirubin transport in the perfused liver of endotoxemic rats
74. Impaired hepatocanalicular organic anion transport in endotoxemic rats
75. Multiple factors regulate the rat liver basolateral sodium-dependent bile acid cotransporter gene promoter
76. Interleukin-1β suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation
77. Identification of a nuclear receptor for bile acids
78. Bile acids: Natural ligands for an orphan nuclear receptor
79. Sodium-independent uptake of bile acids is unaffected by down-regulation of an organic anion transporter (oatp) in rat liver during cholestasis produced by common bile duct ligation (CBDL)
80. Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone
81. Changes in the localization of the rat canalicular conjugate export pump Mrp2 in phalloidin-induced cholestasis
82. Molecular cloning and characterization of the murine bile salt export pump
83. Intrahepatic cholestasis of pregnancy: An estrogen-related disease
84. Changes in biliary excretory mechanisms in rats with ethinyl estradiol-induced cholestasis
85. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver
86. Expression of the liver Na+-independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation
87. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3)
88. Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver
89. The histoautoradiographic localization of taurocholate in rat liver after bile duct ligation
90. Liver regeneration
91. Experimental pathology of liver. 1. Restoration of liver of white rat following partial surgical removal
92. Bile acid metabolism in partially hepatectomized rats
93. Bile secretion and liver regeneration in partially hepatectomized rats
94. Bile secretion by the rat liver during synchronized regeneration
95. Comparison of the effects of two-thirds hepatectomy and bile duct ligation on hepatic excretory function
96. Biliary excretion of drugs in the rat during liver regeneration
97. Regulation of hepatocyte bile salt transporters during hepatic regeneration
98. Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver
99. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats
100. Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication
101. Hepatic basolateral sodium-dependent-bile acid transporter expression in two unusual cases of hypercholanemia and in extrahepatic biliary atresia
102. Identification and functional characterization of the promoter region of the human organic anion transporting polypeptide gene
103. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane
104. Expression of the hepatocyte canalicular multidrug resistance associated protein 2 (MRP2) in primary biliary cirrhosis
105. Human MDR1 and MDR3 gene expression in the liver with obstructive jaundice
106. Semiquantitation of intrahepatic MDR3 mRNA levels by reverse transcription/competitive polymerase chain reaction
107. The bile salt excretory pump (BSEP/SPGP) is not down-regulated in human cholestasis associated with extrahepatic biliary atresia (EHBA)
108. Quantification of hepatobiliary transporter expression in liver biopsies from patients with cholestasis
109. Vanishing bile duct disorder
110. Vanishing bile duct syndrome - From bench to bedside
111. - exchanger in the rat
112. Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter
113. +-dependent bile acid transporter in large but not small rat cholangiocytes
114. Adaptive regulation of the ileal sodium-dependent bile salt transporter (ISBT), and the multispecific organic anion transporter (MRP2), in kidney and cholangiocytes in chronic cholestasis - Alternative pathways for bile salt excretion
115. Carrier-mediated transport of conjugated bile acids across the basolateral membrane of biliary epithelial cells
116. Abnormal expression of anion exchanger genes in primary biliary cirrhosis
117. Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis
118. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis
119. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis
120. Pancreatitis and cystic fibrosis gene mutations
121. MRP3, an organic anion transporter able to transport anti-cancer drugs
122. Byler disease: Fatal familial intrahepatic cholestasis in an Amish kindred
123. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy
124. Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates